# Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on Therapeutics

> **NCT01485328** · PHASE3 · COMPLETED · sponsor: **Laboratorio Saude Ltda.** · enrollment: 60 (actual)

## Conditions studied

- Digestive System Disorders

## Interventions

- **DRUG:** AMARGOL®

## Key facts

- **NCT ID:** NCT01485328
- **Lead sponsor:** Laboratorio Saude Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-04
- **Final completion:** 2009-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485328, "Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on Therapeutics". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01485328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*